Putaminal, but not nigral alterations, characterize hemiparkinsonism-hemiatrophy syndrome: A case report
- 作者Valerio Pisani; Paolo Stanzione; Alessandro Meschini; Simone Marziali; Francesco Giuseppe Garaci; Francesco Brancati; Alessandra Nicoletti; Mario Zappia; Antonio Pisani
- 卷第26卷
- 期第2期
- 印刷ISSN0885-3185
- 电子ISSN1531-8257
- 文件大小510.55KB
- 发表时间2011
- DOI10.1002/mds.23357
- 页码352-354
Advances in clinical trials for movement disordersKieburtz, Karl; Olanow, C. Warren · Movement Disorders · 2015
Initiating levodopa therapy for Parkinson's diseaseOlanow, C. Warren; Kieburtz, Karl; Stocchi, Fabrizio · Movement Disorders · 2014
Huntington's disease: Current and future therapeutic prospectsKieburtz, Karl; Reilmann, Ralf; Olanow, C. Warren · Movement Disorders · 2018
Milestones in movement disorders clinical trials: Advances and landmark studiesC. Warren Olanow; Kathryn B. Wunderle; Karl Kieburtz · 2011
Why have we failed to achieve neuroprotection in Parkinson's disease?C. Warren Olanow; Karl Kieburtz; Anthony H. V. Schapira · 2008
Adverse event reporting in clinical trials in Parkinson's Disease: Time for changeOlanow, C. Warren; Kenney, Christopher; Bandak, Stephen; Kieburtz, Karl D. · Movement Disorders · 2018
Translational experimental therapeutics: The translation of laboratory-based discovery into disease-related therapyKarl Kieburtz; C. Warren Olanow · 2007